TEVA - Teva Alvotech launch biosimilar against AbbVie's Humira
2024-05-21 06:51:13 ET
More on AbbVie, Alvotech, etc.
- AbbVie, Inc. (ABBV) Bank of America Health Care Conference Call Transcript
- Teva Pharmaceutical Industries Limited (TEVA) BofA Securities 2024 Health Care Conference (Transcript)
- Teva Pharmaceutical: 6 Takeaways From Q1 2024 Earnings Results
- AbbVie, Gilgamesh to develop next-generation psychedelic drugs
- Teva hits a five-year high on schizophrenia trial win, Q1 beat